Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd Share Price Today: Live Updates & Key Insights
Get insights on Advanced Enzyme Technologies Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Advanced Enzyme Technologies Ltd Share Price Chart
Advanced Enzyme Technologies Ltd Fundamentals
Traded Volume: 34,557
Market Cap(Cr): 3,497
Avg Traded Price 314.77
1 Year return -17.66%
Upper Circuit 316.9
Lower Circuit 312.3
P/E TTM 24.00
P/B Ratio 13.00
Traded Value(Cr) 107.97
EPS TTM 13.168
Book value 13.168
Dividend Yield 1Y 1.66%
Advanced Enzyme Technologies Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Advanced Enzyme Technologies Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Advanced Enzyme Technologies Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -4.78%
1M +3.51%
3M +3.51%
1Y -17.66%
YTD -10.18%
Advanced Enzyme Technologies Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Advanced Enzyme Technologies Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 87687.00
Day Before Yesterday 97634.00
1W Avg 1.21L
1M Avg 3.91L
3M Avg 5.88L
Advanced Enzyme Technologies Ltd Technical Details
Advanced Enzyme Technologies Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 312
Support 2 309
Support 3 307
Pivot Point : 315
Resistance 1 318
Resistance 2 320
Resistance 3 323
Advanced Enzyme Technologies Ltd Corporate Actions
Advanced Enzyme Technologies Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Advanced Enzyme Technologies Ltd’s capital allocation strategies.
All
Ex-Date 23-Jul-2025 Type D Description 1.20/share@60.00% Record Date 23-Jul-2025 Ratio 60.00
Ex-Date 16-May-2025 Type D Description 4.00/share@200.00% Record Date 17-May-2025 Ratio 200.00
Ex-Date 18-Jul-2024 Type D Description 1.10/share@55.00% Record Date 18-Jul-2024 Ratio 55.00
Ex-Date 17-May-2024 Type D Description 4.00/share@200.00% Record Date 18-May-2024 Ratio 200.00
Ex-Date 04-Aug-2023 Type D Description 1.00/share@50.00% Record Date 05-Aug-2023 Ratio 50.00
Ex-Date 19-May-2023 Type D Description 4.00/share@200.00% Record Date 20-May-2023 Ratio 200.00
Ex-Date 11-Aug-2022 Type D Description 1.00/share@50.00% Record Date 12-Aug-2022 Ratio 50.00
Ex-Date 31-Aug-2021 Type D Description 0.90/share@45.00% Record Date 01-Sep-2021 Ratio 45.00
Ex-Date 09-Jul-2020 Type D Description 0.60/share@30.00% Record Date - Ratio 30.00
Ex-Date 01-Aug-2019 Type D Description 0.60/share@30.00% Record Date - Ratio 30.00
Ex-Date 06-Sep-2018 Type D Description 0.50/share@25.00% Record Date - Ratio 25.00
Ex-Date 04-Sep-2017 Type D Description 0.40/share@20.00% Record Date - Ratio 20.00
Ex-Date 25-May-2017 Type S Description share@1:5.00 Record Date 26-May-2017 Ratio 1:5.00
Dividends
Announcement Date 23-Jul-2025 Ex Dividend Date 23-Jul-2025 Dividend(%) 60
Announcement Date 16-May-2025 Ex Dividend Date 16-May-2025 Dividend(%) 200
Announcement Date 18-Jul-2024 Ex Dividend Date 18-Jul-2024 Dividend(%) 55
Announcement Date 17-May-2024 Ex Dividend Date 17-May-2024 Dividend(%) 200
Announcement Date 04-Aug-2023 Ex Dividend Date 04-Aug-2023 Dividend(%) 50
Announcement Date 19-May-2023 Ex Dividend Date 19-May-2023 Dividend(%) 200
Announcement Date 11-Aug-2022 Ex Dividend Date 11-Aug-2022 Dividend(%) 50
Announcement Date 31-Aug-2021 Ex Dividend Date 31-Aug-2021 Dividend(%) 45
Announcement Date 09-Jul-2020 Ex Dividend Date 09-Jul-2020 Dividend(%) 30
Announcement Date 01-Aug-2019 Ex Dividend Date 01-Aug-2019 Dividend(%) 30
Announcement Date 06-Sep-2018 Ex Dividend Date 06-Sep-2018 Dividend(%) 25
Announcement Date 04-Sep-2017 Ex Dividend Date 04-Sep-2017 Dividend(%) 20
Bonus
No Bonus has been declared by ADVENZYMES
Splits
Record Date 26-May-2017 Split Date 25-May-2017 Face Value (Before/After) 10.00/2.00
Others
Rights No Rights has been declared by ADVENZYMES
Advanced Enzyme Technologies Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Advanced Enzyme Technologies Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Advanced Enzyme Technologies Ltd's relative performance and valuation against major competitors.
Stock Name Biocon Ltd ₹399.20 (+0.19%) M. Cap (Cr) 533.72 1 Yr Return (%) +13.20% P/E (TTM) 109.96 PB Ratio 2.53
Stock Name Concord Biotech Ltd ₹1423.80 (-1.11%) M. Cap (Cr) 148.95 1 Yr Return (%) -31.31% P/E (TTM) 46.03 PB Ratio 8.23
Stock Name Advanced Enzyme Technologies Ltd ₹312.45 (-0.79%) M. Cap (Cr) 34.97 1 Yr Return (%) -17.66% P/E (TTM) 23.77 PB Ratio 2.61
Stock Name Panacea Biotec Ltd ₹367.90 (-1.49%) M. Cap (Cr) 22.53 1 Yr Return (%) -13.02% P/E (TTM) -311.92 PB Ratio 2.71
Stock Name Genesis IBRC India Ltd ₹146.10 (-1.98%) M. Cap (Cr) 1.90 1 Yr Return (%) NaN% P/E (TTM) -820.79 PB Ratio 22.26
Stock Name Alpa Laboratories Ltd ₹79.67 (+2.72%) M. Cap (Cr) 1.68 1 Yr Return (%) -27.84% P/E (TTM) 8.98 PB Ratio 0.98
Stock Name Bharat Immunological & Biological Corporation Ltd ₹20.48 (+1.14%) M. Cap (Cr) 0.88 1 Yr Return (%) -14.38% P/E (TTM) -4.78 PB Ratio 1.01
Advanced Enzyme Technologies Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Advanced Enzyme Technologies Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 63.48 Mar 2024 55.81 Mar 2023 50.30 Mar 2022 37.10 Mar 2021 84.19
PARTICULARS Investing Activities Mar 2025 -1.74 Mar 2024 -6.88 Mar 2023 -42.35 Mar 2022 -14.24 Mar 2021 -69.91
PARTICULARS Financing Activities Mar 2025 -57.63 Mar 2024 -56.88 Mar 2023 -11.99 Mar 2022 -10.87 Mar 2021 -15.45
PARTICULARS Net Cash Flow Mar 2025 4.11 Mar 2024 -7.95 Mar 2023 -4.05 Mar 2022 11.99 Mar 2021 -1.16
Advanced Enzyme Technologies Ltd Shareholding Pattern
This shows the ownership breakdown of Advanced Enzyme Technologies Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 43.07%
Public 25.09%
Other Institutions 3.17%
FII 25.41%
Mutual Funds 3.24%
About Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that transformed business globally in the manufacturing and sale of enzymes. The Company was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra. It thereafter converted the status into a Public Company and the name of the Company was changed to Advanced Biochemicals Limited on May 28, 1992 and further was changed to Advanced Enzyme Technologies Limited via fresh Certificate of Incorporation at RoC, Mumbai on August 19, 2005.In 2011, the company took over Cal-India Foods International, giving the company direct presence in USA.In 2012, the company took over Advanced Supplementary Technologies Corporation for consolidating its presence in USA.Advanced Enzyme Technologies Limited came out with its Initial Public Offer (IPO) of 4,594,875 Equity shares of Rs 10 each at an issue price of Rs 896 per Equity share ( Rs 810 per Equity share for eligible employees), consisting of fresh issue of 560,405 Equity shares and an Offer for Sale of 4,034,470 Equity shares by Selling Shareholders. The IPO was open for subscription during the period from 20 July 2016 to 22 July 2016. The said offer was overall subscribed 82.06 times. The equity shares of Advanced Enzyme Technologies Limited were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on 1 August 2016 at an opening market price of Rs 1,210 on both the exchanges compared with the IPO price of Rs 896 per share.During the financial year ended 31 March 2017, Advanced Enzyme Technologies Limited acquired 1.43 crore equity shares at Rs 35 per share of JC Biotech Private Limited (JCB), aggregating to Rs 50.08 crore, 70% of the paid-up share capital of JCB. In view of this JCB became subsidiary with effect from December 1, 2016.The sub-division of equity shares of the company from face value of 10 each to face value of 2 each (Stock Split) and consequent alteration in Capital Clause of Memorandum of Association of was approved by the company's shareholders on May 04, 2017, through a Postal Ballot. The `Record Date' for the purpose of ascertaining the shareholders entitled to receive the said sub-divided equity shares was fixed by the Board as May 26, 2017. Subsequently, the company issued five (5) sub-divided equity shares of 2 each in lieu of one (1) equity share of 10 each to the eligible shareholders of the company.On 3 July 2017, Advanced Enzyme Technologies completed the acquisition of 200,000 equity shares of MYR 1 (Malaysia Ringgit) each aggregating to MYR 200,000 (equivalent to approx. 3,134,000) of AEM i.e. 80% of paid-up share capital of AEM. The company also subscribed to right issue of 150,000 Equity Shares at MYR 1 per share of AEM, aggregating to MYR 150,000 (equivalent to 2,602,500) on 13 March 2018. On 20 March 2018, the company completed the acquisition of remaining stake i.e. 50,000 equity shares of face value of MYR 1 each of AEM. The said acquisition was made at face value for a total consideration of MYR 50,000 (equivalent to 867,800). In view of the above, AEM has become a wholly-owned subsidiary of the company, effective from March 30, 2018.The company's wholly owned subsidiary, Advanced Enzymes Europe BV acquired 100% stake in evoxx technologies GmbH (evoxx) and evoxx became a step-down subsidiary of the Company in 2020-21. In January 2021, it completed the acquisition of controlling stake of 51% in SciTech Specialities Private Limited (SSPL), India, a contract manufacturing company specializing in effervescent granules and tablets with 2 manufacturing facilities and 1 R&D unit, which became a subsidiary of Company effective from January 11, 2021. On 29 May 2021, Company acquired additional stake of 15% from existing shareholders of JC Biotech Private Limited (JCB) at a consideration of Rs. 211.25 Million. The said acquisition by increase in stake in JCB was completed on August 18, 2021 and the stake of Company in JCB increased from existing 70% to 85%. In 2023, the Company acquired an additional stake of 4.83% in subsidiary, JC Biotech, resulting in a total stake of 89.83%. It acquired 50% stake in Saiganesh Enzytech Solutions Private Limited on 03 January 2023 and it became a subsidiary of the Company. The Company launched Wellfa, a B2C consumer brand and further introduced new products including enzymes for producing chiral/ non-chiral molecules; Pepzyme Pro, clinically proven product for optimizing protein digestion, uptake, and gut modulation; SacchariSEB ML for easily absorbable dietary fiber production; and Code T-400, designed to enhance tea properties.Further, the Company acquired additional stake of 5.89% in its subsidiary JC Biotech Private Limited effective on March 5, 2024 and post the additional acquisition, the Company holds 95.72% stake in the subsidiary.The Company subsidiary Starya Labs Inc, established an independent facility for testing services of enzymes and probiotic product in the US market in FY 2025.
Whole-time director
MUKUND MADHUSUDAN KABRA
Registered office Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi, Thane, Maharashtra, 400604
FAX :91-22-41703200
Background
Incorporation Year 1989
Face Value ₹2.00
Market Lot 1
FAQs on Advanced Enzyme Technologies Ltd
How to buy Advanced Enzyme Technologies Ltd shares on NSE?
To buy Advanced Enzyme Technologies Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Advanced Enzyme Technologies Ltd share price today?
The Advanced Enzyme Technologies Ltd share price on NSE is ₹312.45 today.
What is the market cap of Advanced Enzyme Technologies Ltd on NSE?
The company has a market capitalization of ₹3497.15.
What is the PE & PB ratio of Advanced Enzyme Technologies Ltd?
PE is 24 and PB is 13.
What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd shares?
Advanced Enzyme Technologies Ltd stock price high: ₹411.40 Advanced Enzyme Technologies Ltd stock price low: ₹257.90.